A positive highlight of the COVID-19 situation has been the large number of grassroots-level innovations brought forth by Indian start-ups, entrepreneurs, and researchers to counter the pandemic. A thriving culture of innovation and entrepreneurship is necessary to nurture this spirit. In this regard, the fourth edition of the National Bio Entrepreneurship Competition (NBEC) is currently open for applications.
Early diagnosis is critical for the effective treatment of cancer and there has been a strong push for non-invasive and rapid techniques to detect malignant cells. In a new study, researchers from S N Bose National Centre for Basic Sciences, Saha Institute of Nuclear Physics, and Bose Institute, Kolkata have come up with a method to identify colon cancer cells using a biomarker that can be detected in low levels in bodily fluids.
In the last few years, research into engineered microscopic particles (nanobots) that can navigate through the body to deliver drugs with precision has intensified. Now, Researchers from IIT Guwahati have come up with nanobots synthesized from tea extracts, playfully named 'teabots', which can serve as biocompatible drug-delivery agents.
Tuberculosis is an infectious disease that kills lakhs of Indians every year. Early detection of the disease is key to administering treatment; however, this has been hampered by the fact that current diagnostic techniques are often costly and time-consuming. Now, researchers from the Indian Institute of Science, Bengaluru, have come up with an inexpensive paper-based diagnostic device for tuberculosis detection.
As the problem of antibiotic resistance mounts worldwide, there is a pressing need for identifying and testing novel drug targets. Recently, a team of researchers from the Indian Institute of Science Education and Research (IISER), Pune, and the Central Drug Research Institute (CSIR-CDRI), Lucknow, has identified a protein pathway in an antibiotic-resistant bacterial strain which can be targeted using a small molecule to effectively kill the bacteria.
A recurring challenge for combination cancer therapy has been delivering drugs with widely differing properties to the tumour site. Now, researchers at the Regional Centre for Biotechnology, Faridabad, and Amity University, Haryana, have come up with a novel strategy for combining three different drugs into a single package that can induce tumour shrinkage when injected.
Uncontrolled blood loss following an accident or injury can pose severe risks to the health and life of the patient. Now, a team of Indian researchers from the Institute of Nano Science and Technology have developed a novel environment-friendly microparticle which can stop bleeding quickly if applied to the injury site.